Natural history of retinitis pigmentosa based on genotype, vitamin A/E supplementation, and an electroretinogram biomarker
Jason Comander(Massachusetts Eye and Ear Infirmary), Eric A. Pierce(Broad Institute), Erin Zampaglione(Massachusetts Eye and Ear Infirmary), Rachel M. Huckfeldt(Penn Presbyterian Medical Center), Matthew Maher(James J. Peters VA Medical Center), Kit Sanderson(Massachusetts Eye and Ear Infirmary), Emily Place(MACOM (United States)), Kinga M. Bujakowska(Massachusetts Eye and Ear Infirmary), Yan Zhao(Nanyang Technological University), Carol Weigel DiFranco(Massachusetts Eye and Ear Infirmary)
Cited by 40
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k